Recall D-0264-2022
Description: Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.
Recall D-0264-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0264-2022 |
| Event ID | 89085 |
| Distribution | nationwide within the United States |
| Quantity | 4113 cartons |
| Recall Reason | Subpotent Drug |
| Drug Classification | Class III |
| Drug Code Info | 20211208 |
| Recall Initiation Date | 20211119 |
| Report Date | 20211208 |
| Classification Date | 20211201 |
| Address | Harborplace Tower111 S Calvert St Fl 21st Baltimore, MD 21202-6174 United States |
| Recalling Firm | Lupin Pharmaceuticals Inc. |
| Initial Notification | Letter |
| Similar To |